Novel biomarkers are needed to direct new treatments for ovarian cancer, a disease for
which the standard of care remains heavily focused on platinum-based chemotherapy …

Cancer is the second leading cause of fatalities at the global level, and the involvement of
microbes in several diseases, including cancer is well known. The gut microbiome is known …

Ovarian cancer is the deadliest of all gynecologic malignancies claiming the lives of nearly
14,000 women in the United States annually. Despite therapeutic advances, the ovarian …

Ovarian cancer (OC) is one of the most common gynecological cancers, with the worst
prognosis and the highest mortality rate. Peritoneal dissemination (or carcinomatosis) …

Background Ovarian cancer is usually detected at later stages and no effective screening
approach, has been identified. Therefore, sensitive and specific biomarkers for detecting …

Simple Summary Ovarian cancer is the most lethal gynecological malignancy. Cancer stem
cells have been implicated in tumor initiation, progression, and invasion, as well as tumor …

SYNE1, a nuclear envelope protein critical for cellular structure and signaling, is
downregulated in numerous malignancies. SYNE1 alterations are found in 10% of …

Humanity is currently facing various diseases with significant mortality rates, particularly
those associated with malignancies. Numerous enzymes and proteins have been identified …

Introduction Ovarian cancer (OC) is a gynecological tumor disease, which is usually
diagnosed at an advanced stage and has a poor prognosis. It has been established that the …

Ovarian cancer is one of the deadliest cancers in women. The lack of specific symptoms,
especially at the initial stages of disease development, together with the malignancy …